DE69321914T2 - Antikörper gegen Plasmodium falciparum - Google Patents

Antikörper gegen Plasmodium falciparum

Info

Publication number
DE69321914T2
DE69321914T2 DE69321914T DE69321914T DE69321914T2 DE 69321914 T2 DE69321914 T2 DE 69321914T2 DE 69321914 T DE69321914 T DE 69321914T DE 69321914 T DE69321914 T DE 69321914T DE 69321914 T2 DE69321914 T2 DE 69321914T2
Authority
DE
Germany
Prior art keywords
hrp
antibody
peptide
monoclonal antibody
plasmodium falciparum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69321914T
Other languages
German (de)
English (en)
Other versions
DE69321914D1 (de
Inventor
Hans H. Parkton Maryland 21120 Feindt
Gerald D. Severn Maryland 21144 Hahn
Melissa S. Laytonsville Maryland 20760 Maret
Keith West Friendship Maryland 21794 Uithoven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of DE69321914D1 publication Critical patent/DE69321914D1/de
Application granted granted Critical
Publication of DE69321914T2 publication Critical patent/DE69321914T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69321914T 1992-09-11 1993-08-27 Antikörper gegen Plasmodium falciparum Expired - Fee Related DE69321914T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94528792A 1992-09-11 1992-09-11

Publications (2)

Publication Number Publication Date
DE69321914D1 DE69321914D1 (de) 1998-12-10
DE69321914T2 true DE69321914T2 (de) 1999-03-25

Family

ID=25482919

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69321914T Expired - Fee Related DE69321914T2 (de) 1992-09-11 1993-08-27 Antikörper gegen Plasmodium falciparum

Country Status (10)

Country Link
US (3) US5478741A (cg-RX-API-DMAC10.html)
EP (1) EP0588122B1 (cg-RX-API-DMAC10.html)
JP (1) JP2537589B2 (cg-RX-API-DMAC10.html)
AU (2) AU670108B2 (cg-RX-API-DMAC10.html)
CA (1) CA2104899C (cg-RX-API-DMAC10.html)
DE (1) DE69321914T2 (cg-RX-API-DMAC10.html)
ES (1) ES2124276T3 (cg-RX-API-DMAC10.html)
MY (1) MY109957A (cg-RX-API-DMAC10.html)
SG (1) SG48314A1 (cg-RX-API-DMAC10.html)
TW (1) TW258738B (cg-RX-API-DMAC10.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
GB9505447D0 (en) * 1995-03-17 1995-05-03 Common Services Agency Competitive binding assay
US20030036106A1 (en) * 1996-10-28 2003-02-20 Burke Thomas J. Kinase and phosphatase activity measurement using fluorescence polarization
JP2001527412A (ja) * 1997-05-14 2001-12-25 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 抗菌ペプチド
US20020102620A1 (en) * 1999-05-07 2002-08-01 S. Melissa Maret Antibodies and peptides for detection of plasmodium vivax
DE60012932T2 (de) * 1999-06-23 2005-08-18 Cornell Research Foundation, Inc. Entwässerung/rehydratisierung von markierten liposomen auf einer prüfeinrichtung
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
WO2003102541A2 (en) 2002-05-31 2003-12-11 Cornell Research Foundation, Inc. Universal biosensor and methods of use
AU2003270619A1 (en) 2002-09-12 2004-04-30 Molecular Probes, Inc. Site-specific labeling of affinity tags in fusion proteins
FR2865541B1 (fr) * 2003-05-20 2006-08-11 Commissariat Energie Atomique Procede de detection de fluorure ou de fluorure d'hydrogene et trousse de detection
EP1718967B1 (en) * 2004-02-03 2013-04-24 Diadexus, Inc. METHODS OF DETECTING Lp-PLA2 ACTIVITY
KR101035111B1 (ko) * 2004-06-30 2011-05-19 주식회사 엘지생명과학 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단
JP4508765B2 (ja) * 2004-08-02 2010-07-21 東洋紡績株式会社 ペプチドの固定化方法
JP4599928B2 (ja) * 2004-08-02 2010-12-15 東洋紡績株式会社 ペプチドの固定化方法
US9568471B2 (en) * 2005-01-25 2017-02-14 The Johns Hopkins University Plasmodium diagnostic assay device
ATE476655T1 (de) * 2005-03-30 2010-08-15 Saladax Biomedical Inc Doxorubicin-immuntest
US20070072242A1 (en) * 2005-09-22 2007-03-29 Randox Laboratories Limited Immunoassay method and kit to leucomalachite green and malachite green
EP1991273B2 (en) * 2006-02-10 2022-01-05 Life Technologies Corporation Labeling and detection of post translationally modified proteins
ES2553141T3 (es) * 2006-05-27 2015-12-04 Fluidigm Canada Inc. Marcadores elementales de cadena principal polimérica
WO2008008797A2 (en) 2006-07-10 2008-01-17 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
WO2008039266A2 (en) * 2006-07-28 2008-04-03 Beckman Coulter, Inc. Stabilizing agents and capture ligands for use in assays measuring analyte concentrations
CA2665165C (en) 2006-10-06 2014-12-16 Sirigen Inc. Fluorescent methods and materials for directed biomarker signal amplification
TWI368905B (en) 2006-11-17 2012-07-21 Princeton Technology Corp Circuits for generating radio frequency zero cross signal of optical disc drive
US9239329B2 (en) * 2006-12-18 2016-01-19 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
FR2914066B1 (fr) * 2007-03-20 2009-05-22 Polyintell Sarl Kit d'analyse comprenant au moins deux polymeres a empreintes moleculaires et au moins un marqueur, ainsi que le procede d'analyse l'utilisant
US8320230B2 (en) 2007-05-17 2012-11-27 Mediatek Inc. Processing circuits and methods for optical data
US7943370B2 (en) * 2007-08-23 2011-05-17 Canon Kabushiki Kaisha Structure, target substance detection element and target substance detection kit
US8556843B2 (en) * 2008-02-02 2013-10-15 AccelDx Blood purification method and apparatus for the treatment of malaria
WO2010051544A2 (en) * 2008-10-31 2010-05-06 Lumiphore, Inc. Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
US9273059B2 (en) 2009-08-24 2016-03-01 Lumiphore, Inc. Macrocyclic HOPO chelators
WO2011079291A1 (en) * 2009-12-24 2011-06-30 Lumiphore, Inc. Radiopharmaceutical complexes
US20130131104A1 (en) * 2010-03-23 2013-05-23 Board Of Trustees Of Michigan State University Histidine rich protein-2 diagnostic test for cerebral malaria
KR20130107293A (ko) * 2010-09-03 2013-10-01 오레곤 헬스 앤드 사이언스 유니버시티 공유 결합된 펩티드를 갖는 재조합 ｔ 세포 수용체 리간드
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
WO2015084994A1 (en) * 2013-12-03 2015-06-11 President And Fellows Of Harvard College Methods and reagents for the assessment of gestational diabetes
GB201409516D0 (en) * 2014-05-29 2014-07-16 Randox Lab Ltd Immunoassay for compounds of the NBOMe family
EP3265074B1 (en) * 2015-03-03 2020-08-12 ARK Diagnostics, Inc. Pregabalin immunoassays
EP3288912A4 (en) * 2015-05-01 2018-11-07 Biolegend, Inc. Stable nanomagnetic particle dispersions
CN108884030B (zh) * 2016-02-26 2022-06-28 安捷伦科技有限公司 使用双吡啶改善亲核物质的标记
CA3019498A1 (en) * 2016-04-05 2017-10-12 Universite De Strasbourg Intra-droplet surface engineering to capture a molecular target
US11608489B2 (en) 2016-04-30 2023-03-21 BioLegend, Inc. Compositions and methods for performing magnetibuoyant separations
JP7303182B2 (ja) 2017-04-21 2023-07-04 メリタス エルエルシー 糖尿病関連用途のための方法及び抗体
CN120801474A (zh) * 2018-04-13 2025-10-17 富鲁达加拿大公司 用于元素分析的稳定细胞采集
CN111378035B (zh) * 2018-12-29 2021-10-08 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii重组抗体
CN111378034B (zh) * 2018-12-29 2021-10-12 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii抗体
CN114605533B (zh) * 2020-12-08 2023-02-28 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii的抗体、检测恶性疟原虫的试剂和试剂盒
US20220214350A1 (en) * 2021-01-05 2022-07-07 Encodia, Inc. Methods for stable complex formation and related kits

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388694B (sv) 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4666866A (en) 1983-04-19 1987-05-19 Krauth Gary H Immunoassay for antigens employing supported binder
US4493795A (en) * 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4695554A (en) 1984-02-14 1987-09-22 Becton Dickinson And Company Sac or liposome containing dye (sulforhodamine) for immunoassay
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US4743560A (en) 1984-03-26 1988-05-10 Becton Dickinson And Company Solid phase assay
US4632901A (en) 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
GB2169901A (en) 1984-12-11 1986-07-23 Lkb Biochrom Ltd method for a solid phase synthesis of a linear combination of amino acid residues.
AU5603786A (en) * 1985-04-11 1986-10-16 Walter And Eliza Hall Institute Of Medical Research, The Highly repetitive antigens - sharp-arp-mesa-plasmodium falciparum
ZW8386A1 (en) * 1985-04-11 1986-07-23 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
US5130416A (en) * 1986-08-13 1992-07-14 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum
US5030558A (en) 1986-11-07 1991-07-09 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
US4920046A (en) 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
US4855240A (en) 1987-05-13 1989-08-08 Becton Dickinson And Company Solid phase assay employing capillary flow
WO1989001785A1 (en) 1987-09-04 1989-03-09 Georgetown University Monoclonal antibodies to a plasmodium falciparum protein
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
US4818677A (en) 1987-12-03 1989-04-04 Monoclonal Antibodies, Inc. Membrane assay using focused sample application
US5096837A (en) 1990-02-08 1992-03-17 Pacific Biotech, Inc. Immunochromatographic assay and method of using same
EP0474891A1 (en) * 1990-09-08 1992-03-18 BEHRINGWERKE Aktiengesellschaft Vectors for expression of malarial antigens on the surface of Salmonella vaccine strains
JP2002054521A (ja) 2000-08-11 2002-02-20 Honda Motor Co Ltd エンジンの燃料ポンプ取付構造

Also Published As

Publication number Publication date
TW258738B (cg-RX-API-DMAC10.html) 1995-10-01
AU6449996A (en) 1996-12-12
US5665552A (en) 1997-09-09
JP2537589B2 (ja) 1996-09-25
US5478741A (en) 1995-12-26
AU4487293A (en) 1994-03-17
SG48314A1 (en) 1998-04-17
CA2104899A1 (en) 1994-03-12
CA2104899C (en) 2000-10-17
DE69321914D1 (de) 1998-12-10
EP0588122B1 (en) 1998-11-04
MY109957A (en) 1997-10-31
EP0588122A1 (en) 1994-03-23
US5604117A (en) 1997-02-18
AU683000B2 (en) 1997-10-23
JPH06225789A (ja) 1994-08-16
AU670108B2 (en) 1996-07-04
ES2124276T3 (es) 1999-02-01

Similar Documents

Publication Publication Date Title
DE69321914T2 (de) Antikörper gegen Plasmodium falciparum
DE69622385T2 (de) Verbindungen und verfahren zum nachweis von t. cruzi-infektion
DE69432629T2 (de) Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
DE69733560T2 (de) TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
Kaushal et al. Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes.
DE69321955T2 (de) Bnp antikörper und immunologischer nachweis der ihn benutzt
DE69228436T2 (de) Monoklonaler Antikörper, der den C-Terminus von hBNP erkennt
Butterworth et al. Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity
DE60224346T2 (de) Monoklonales Antikörper gegen das HCV Kernantigen
EP1110970B1 (de) Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
DE3486159T2 (de) Schuetzendes peptid-antigen.
DE69132122T2 (de) Reinigung von cytokeratinfragmenten
DE69504620T2 (de) Monoklonaler Antikörper gegen menschliches Glicentin, Hybridoma zur Herstellung dieses Antikörpers und Testverfahren für menschliches Glicentin unter Verwendung dieses Antikörpers
DE60219645T2 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
DE69619405T2 (de) Verbindungen und verfahren zum nachweis und zur vorbeugung von t.cruzi infektionen
DE3884646T2 (de) Humanes Karcinom-assoziertes Antigen und an dieses Antigen bindende Antikörper.
EP0142345A2 (en) Anti-idiotypic vaccine employing anti-idiotypic monoclonal antibodies
DE69733957T2 (de) Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta
DE4024919A1 (de) Peptide mit fuer (alpha)1-mikroglobulin charakteristischer antigener determinante
DE69229230T2 (de) Antikörpertest zur erkennung von alkoholikern und zur überwachung der alkoholaufnahme
DE69230614T2 (de) Protein-s polypeptide und deren verwendungen
AU618024B2 (en) Antibodies to angiogenin: immunotherapeutic agents
US20020102620A1 (en) Antibodies and peptides for detection of plasmodium vivax
DE69229948T2 (de) hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN
DE68917797T2 (de) Gegen menschliches Fibrinopepid A spezifische monoklonale Antikörper.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee